Invesco Pharmaceuticals ETFPJP
PJP
0
Funds holding %
of 6,809 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
160% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 5
9% more funds holding
Funds holding: 88 [Q2] → 96 (+8) [Q3]
4% less capital invested
Capital invested by funds: $68.4M [Q2] → $66M (-$2.41M) [Q3]
1.88% less ownership
Funds ownership: 24.87% [Q2] → 22.99% (-1.88%) [Q3]
31% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 29
Research analyst outlook
We haven’t received any recent analyst ratings for PJP.
Financial journalist opinion
Neutral
Zacks Investment Research
1 week ago
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the Invesco Pharmaceuticals ETF (PJP), a passively managed exchange traded fund launched on 06/23/2005.
Neutral
Zacks Investment Research
1 month ago
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
The Invesco Pharmaceuticals ETF (PJP) was launched on 06/23/2005, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
Neutral
Zacks Investment Research
2 months ago
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
The Invesco Pharmaceuticals ETF (PJP) was launched on 06/23/2005, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity market.
Neutral
Zacks Investment Research
3 months ago
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
The Invesco Pharmaceuticals ETF (PJP) made its debut on 06/23/2005, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.
Positive
Seeking Alpha
4 months ago
PJP: A Dynamic Pharma Fund
Bullish on pharmaceuticals and health care due to relative momentum and preference for "need" sectors over cyclical ones. The Invesco Pharmaceuticals ETF provides exposure to select pharmaceutical stocks with specific criteria for selection and a dynamic approach. The fund holds 24 stocks, primarily in pharmaceuticals, biotech, and healthcare equipment, with heavyweights like AbbVie, Regeneron, Eli Lilly, and Abbott Laboratories.
Positive
Zacks Investment Research
4 months ago
Pharma ETFs in Focus Post Solid Q2 Earnings
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
Neutral
ETF Trends
4 months ago
Disruptive Theme of the Week: Playing Defense
When markets correct, it is a good time to revisit which equity market sectors are “defensive” themes. Certain products and services are nondiscretionary in nature that we cannot live without.
Neutral
Zacks Investment Research
4 months ago
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the Invesco Pharmaceuticals ETF (PJP) is a passively managed exchange traded fund launched on 06/23/2005.
Neutral
Zacks Investment Research
5 months ago
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
Designed to provide broad exposure to the Health Care ETFs category of the market, the Invesco Pharmaceuticals ETF (PJP) is a smart beta exchange traded fund launched on 06/23/2005.
Neutral
Zacks Investment Research
6 months ago
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the Invesco Pharmaceuticals ETF (PJP), a passively managed exchange traded fund launched on 06/23/2005.
Charts implemented using Lightweight Charts™